PWA
ABBV icon

Pitcairn Wealth Advisors’s AbbVie ABBV Stock Holding History

Pitcairn Wealth Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.07M Sell
4,269
-653
-13% -$140K 0.12% 92
2026
Q1 		$1.12M Sell
4,922
-200
-4% -$44.4K 0.1% 86
2025
Q4 		$1.17M Buy
+5,122
New +$1.17M 0.11% 84

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Pitcairn Wealth Advisors's ABBV Position: Q2 2026 in Review

Pitcairn Wealth Advisors reduced its AbbVie (ABBV) stake by 13% in Q2 2026, selling an estimated $140K and leaving 4,269 shares worth $1.07M. The position accounts for 0.12% of the portfolio, ranked #92.

Pitcairn Wealth Advisors first reported a position in ABBV in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.17M in Q4 2025. 4,208 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Pitcairn Wealth Advisors held 4,269 shares of AbbVie worth $1.07M as of Q2 2026.
  • Pitcairn Wealth Advisors sold 653 AbbVie shares in Q2 2026, an estimated $140K.
  • AbbVie made up 0.12% of Pitcairn Wealth Advisors's portfolio in Q2 2026, its #92 holding.
  • Pitcairn Wealth Advisors first reported a position in AbbVie in Q4 2025 and has held it in 3 quarters since.
  • Pitcairn Wealth Advisors's AbbVie position peaked at $1.17M in Q4 2025.
  • 4,208 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Pitcairn Wealth Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.